in Australia. There is already a clutch of candidate RSV vaccines in late-stage development – including GSK's own shot which is heading for regulatory filings after clearing a phase 3 test last ...

with Australia and the European Union also doing the same. Zantac was also recalled by the US Food and Drug Administration ...

(Reuters) -Haleon missed third-quarter revenue and profit expectations on Thursday, hit by a stronger pound and lower sales ...

GSK , Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a health official said on Friday during a press briefing.

In what now seems like an act of reckless naivety, I bought my brother a 23andMe at-home DNA-test birthday present. Now the ...

Currency fluctuations meant Haleon saw year-on-year reported revenue slip 0.6% to £2.78bn in the third quarter, below ...

GSK has developed a new propellant technology ... Last month, a survey of more than 1,300 people from the US, UK, France, and Australia found that there is strong support for pharma manufacturers ...

GSK is delivering consistent financial performance ... So, for example, [indiscernible] in Latin America is more focused on maternal as is Australia, whereas the European markets are more focused ...

GSK Philippines recently announced that announced on Tuesday that the Philippine Food and Drug Administration (FDA) has approved its Meningococcal Group B Vaccine (recombinant, adsorbed), for the ...

Moderna Inc (MRNA) reports $1.9 billion in revenue and outlines future growth strategies despite competitive pressures and ...